Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119273) titled 'Establishment and Application of a CRISPR-Based Detection Method for Bloodstream Infection and Respiratory Tract Infection' on Feb. 25.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: Renji Hospital affiliated to Shanghai Jiaotong University School of Medicine
Condition:
Bloodstream infections and respiratory tract associated pathogen infections
Intervention:
Gold Standard:The test to be evaluated in this study is a CRISPR-based detection method, and the gold standard is the culture method. The culture-based detection method is highly recognized in clinical testing,...